EPIX ESSA Pharma Inc. Stock Quote

EPIX [NASD]

Index	-	P/E	-	EPS (ttm)	-0.92	Insider Own	2.40%	Shs Outstand	36.48M	Perf Week	-1.24%
Market Cap	1.10B	Forward P/E	-	EPS next Y	-1.25	Insider Trans	6.78%	Shs Float	32.73M	Perf Month	12.28%
Income	-29.00M	PEG	-	EPS next Q	-0.26	Inst Own	66.10%	Short Float	0.83%	Perf Quarter	3.82%
Sales	-	P/S	-	EPS this Y	30.90%	Inst Trans	16.89%	Short Ratio	0.90	Perf Half Y	362.36%
Book/sh	5.63	P/B	5.21	EPS next Y	-	ROA	-	Target Price	-	Perf Year	527.35%
Cash/sh	5.58	P/C	5.27	EPS next 5Y	-	ROE	-	52W Range	4.36 - 32.69	Perf YTD	146.10%
Dividend	-	P/FCF	-	EPS past 5Y	39.20%	ROI	-	52W High	-10.19%	Beta	1.68
Dividend %	-	Quick Ratio	65.80	Sales past 5Y	-	Gross Margin	-	52W Low	573.39%	ATR	1.89
Employees	11	Current Ratio	65.80	Sales Q/Q	-	Oper. Margin	-	RSI (14)	53.03	Volatility	6.58% 7.33%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	20.90%	Profit Margin	-	Rel Volume	0.78	Prev Close	27.15
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 06 AMC	Payout	-	Avg Volume	299.52K	Price	29.36
Recom	-	SMA20	3.23%	SMA50	1.19%	SMA200	93.56%	Volume	235,598	Change	8.14%

Mar-04-21

Initiated

Piper Sandler

Overweight

$50

Jan-11-21

Reiterated

H.C. Wainwright

Buy

$10 → $17

Nov-02-20

Initiated

Jefferies

Buy

$17

Oct-25-19

Initiated

Oppenheimer

Outperform

May-10-21 10:59AM	EPIX: Combination Trials Upcoming with Astellas, Bayer, and Janssen Zacks Small Cap Research
May-06-21 07:01AM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2021 PR Newswire
07:01AM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2021 CNW Group
Apr-28-21 07:00AM	ESSA Pharma Announces Clinical Collaboration Agreement with Bayer to Evaluate the Combination of EPI-7386 and Darolutamide in Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire +7.20%
07:00AM	ESSA Pharma Announces Clinical Collaboration Agreement with Bayer to Evaluate the Combination of EPI-7386 and Darolutamide in Patients with Metastatic Castration-Resistant Prostate Cancer CNW Group
Apr-14-21 07:00AM	ESSA Pharma to Present at the Bloom Burton & Co. Healthcare Investor Conference PR Newswire
07:00AM	ESSA Pharma to Present at the Bloom Burton & Co. Healthcare Investor Conference CNW Group
Apr-12-21 10:50AM	EPIX: Additional Preclinical Data Shows EPI-7386 Inhibits AR-Driven Transcription Zacks Small Cap Research
Apr-10-21 08:30AM	ESSA Pharma Presents Preclinical Data Supporting the Therapeutic Potential of EPI-7386 at the 2021 American Association of Cancer Research (AACR) Annual Meeting PR Newswire
08:30AM	ESSA Pharma Presents Preclinical Data Supporting the Therapeutic Potential of EPI-7386 at the 2021 American Association of Cancer Research (AACR) Annual Meeting CNW Group
Mar-26-21 04:05PM	ESSA Announces Change to its Board of Directors PR Newswire
04:05PM	ESSA Announces Change to its Board of Directors CNW Group
Mar-04-21 11:32AM	ESSA Pharma Announces Exercise of Option in Connection with Recently Completed $130 Million Financing PR Newswire
11:32AM	ESSA Pharma Announces Exercise of Option in Connection with Recently Completed $130 Million Financing CNW Group
Mar-02-21 08:00AM	LAWSUIT FILED: Ebix, Inc. Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLP ACCESSWIRE
Feb-25-21 06:33PM	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders PR Newswire
04:30PM	ESSA Pharma to Present at Upcoming March Investor Conferences PR Newswire
04:30PM	ESSA Pharma to Present at Upcoming March Investor Conferences CNW Group
07:00AM	ESSA Pharma Announces Clinical Collaboration with Astellas to Evaluate the Combination of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer CNW Group
Feb-22-21 11:48AM	ESSA Pharma Announces Closing of $130 Million Public Offering of Common Stock PR Newswire
11:48AM	ESSA Pharma Announces Closing of $130 Million Public Offering of Common Stock CNW Group
Feb-17-21 10:47PM	ESSA Pharma Announces Pricing of Public Offering of Common Shares PR Newswire +9.31%
Feb-16-21 04:01PM	ESSA Pharma Announces Proposed Public Offering of Common Shares PR Newswire -11.92%
08:30AM	Premier Gold Reminds Securityholders of Special Meeting on February 23, 2021 and Provides Update to certain Special Meeting Business relating to SpinCo Financing CNW Group
Feb-12-21 04:40AM	EPIX: Encouraging Initial Clinical Data for EPI-7386 Zacks Small Cap Research
Feb-11-21 10:38AM	ESSA Pharma's Interim EPI-7386 Data Shows Continuous Antigen Decline In Early-Stage Prostate Cancer Study Benzinga +47.91%
08:02AM	ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium PR Newswire
08:02AM	ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium CNW Group
07:00AM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2020 PR Newswire
07:00AM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2020 CNW Group
Feb-05-21 04:53PM	Statement by the Prime Minister on the death of Christopher Plummer CNW Group
Jan-13-21 07:00AM	ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire +11.62%
07:00AM	ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer CNW Group
Jan-08-21 02:50PM	Media Advisory - Aviation Expert Lawyer Rod Winsor Available to Answer Compensation Questions for Families of Ukraine International Airline Victims CNW Group -6.09%
Dec-17-20 06:27AM	EPIX: Clinical Data for EPI-7386 in 2021 Zacks Small Cap Research
Dec-15-20 07:50PM	Is EPIX A Good Stock To Buy Now? Insider Monkey +7.21%
05:01PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2020 PR Newswire
05:01PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2020 CNW Group
Dec-08-20 09:14AM	IIROC Trade Resumption - BETR CNW Group
Nov-25-20 07:00AM	ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference PR Newswire
Nov-13-20 12:58PM	IIROC Trading Halt - Enter Symbol(s) Here CNW Group
Nov-10-20 07:00AM	ESSA Pharma to Participate in Upcoming Investor Conferences PR Newswire
Oct-26-20 05:01PM	ESSA Pharma Inc. Announces Delisting from the TSX-V PR Newswire
Oct-24-20 07:18PM	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium PR Newswire
Oct-19-20 07:00AM	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia PR Newswire
07:00AM	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia CNW Group
Sep-21-20 07:00AM	ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit PR Newswire
07:00AM	ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit CNW Group
Sep-17-20 05:05PM	ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020 PR Newswire
Sep-14-20 07:00AM	ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resistant Prostate Cancer PR Newswire
Sep-10-20 07:00AM	ESSA Pharma to Participate in Multiple Upcoming Investor Conferences PR Newswire
Aug-12-20 09:22AM	EPIX: $45 Million Financing Includes Investment from Pfizer; Dosing Begins in Phase 1 Trial of EPI-7386 Zacks Small Cap Research
Aug-07-20 06:16AM	Franklin Berger Is The Independent Director of ESSA Pharma Inc. (CVE:EPI) And They Just Picked Up 18% More Shares Simply Wall St.
Aug-06-20 08:00PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020 PR Newswire
Jul-31-20 10:16AM	ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000 PR Newswire
Jul-28-20 09:18PM	ESSA Pharma Announces Pricing of Public Offering of Common Shares PR Newswire
04:01PM	ESSA Pharma Announces Proposed Public Offering of Common Shares PR Newswire
Jul-17-20 09:37AM	Have Insiders Been Buying ESSA Pharma Inc. (CVE:EPI) Shares? Simply Wall St.
Jul-15-20 07:00AM	ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostrate Cancer CNW Group +8.15%
Jun-22-20 07:30AM	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II PR Newswire
07:30AM	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II CNW Group
Jun-04-20 06:25PM	Hedge Funds Are Souring On ESSA Pharma Inc. (EPIX) Insider Monkey
May-27-20 07:00AM	ESSA Pharma to Present at Jefferies Virtual Healthcare Conference PR Newswire
07:00AM	ESSA Pharma to Present at Jefferies Virtual Healthcare Conference CNW Group
05:32AM	EPIX: Additional Preclinical Data Presented at AUA 2020 Zacks Small Cap Research
May-18-20 08:13AM	ESSA Pharma Inc. (CVE:EPI): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
May-15-20 07:30AM	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting CNW Group
May-12-20 07:25AM	EPIX: FDA Gives OK to Initiate Phase 1 Trial of EPI-7386 Zacks Small Cap Research
May-07-20 05:05PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020 PR Newswire
05:05PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020 CNW Group
May-01-20 07:54AM	The Daily Biotech Pulse: Gilead Slips Despite Forecast-Beating Q1, Moderna Partners With Lonza For Coronavirus Vaccine Production, Lyra Therapeutics IPO Benzinga
Apr-30-20 05:45PM	ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer PR Newswire
05:45PM	ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer CNW Group
Apr-13-20 06:08PM	ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement PR Newswire
06:08PM	ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement CNW Group
Apr-02-20 05:45AM	EPIX: EPI-7386 IND Filed Zacks Small Cap Research
Mar-31-20 07:00AM	ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update PR Newswire
07:00AM	ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update CNW Group
Mar-24-20 04:00PM	Solebury Trout Announces Virtual Conference Series with Presentations from Life Science Companies ACCESSWIRE +5.27%
Mar-19-20 09:18AM	ESSA Pharma (CVE:EPI) Is In A Good Position To Deliver On Growth Plans Simply Wall St. +8.36%
Feb-27-20 07:51PM	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders PR Newswire
Feb-18-20 06:10AM	EPIX: IND Filing for EPI-7386 in 1Q20 Zacks Small Cap Research
Feb-13-20 05:48PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019 PR Newswire
05:48PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019 CNW Group
Feb-10-20 06:15PM	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia CNW Group
Dec-30-19 06:15AM	EPIX: Phase 1 Clinical Trial for EPI-7386 to Initiate in 1Q20 Zacks Small Cap Research
Dec-22-19 06:41PM	Hedge Funds Have Never Been This Bullish On ESSA Pharma Inc. (EPIX) Insider Monkey
Dec-19-19 05:15PM	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2019 PR Newswire
Dec-12-19 11:35AM	Janpix, Inc. Announces Appointment of Sanford (Sandy) Zweifach as Executive Chairman to its Board of Directors GlobeNewswire
Dec-03-19 11:00AM	How Many ESSA Pharma Inc. (CVE:EPI) Shares Did Insiders Buy, In The Last Year? Simply Wall St. -9.92%
Nov-11-19 09:00AM	Encode Ideas, L.P. Announces the Initiation of Research Coverage on ESSA Pharma, Inc. Newsfile
Oct-30-19 06:00AM	ESSA Pharma Grants Stock Options PR Newswire
06:00AM	ESSA Pharma Grants Stock Options CNW Group
Oct-28-19 07:30AM	ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics CNW Group +5.75%
Oct-18-19 04:15PM	ESSA Announces Changes to its Board of Directors PR Newswire +8.23%
04:15PM	ESSA Announces Changes to its Board of Directors CNW Group
Oct-11-19 08:15AM	EPIX: New Preclinical Data for EPI-7386 Presented at ESMO 2019 Zacks Small Cap Research +6.20%
Oct-07-19 02:04PM	ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants PR Newswire
02:04PM	ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants CNW Group
Sep-28-19 07:29AM	ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress PR Newswire

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BERGER FRANKLIN M	Director	Feb 22	Buy	27.00	57,000	1,539,000	957,244	Mar 04 06:47 PM
BERGER FRANKLIN M	Director	Dec 03	Option Exercise	3.64	42,207	153,701	900,244	Jan 11 04:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience